- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
PROXEN 250 - 250mg - 20
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M01AE02 | B | Naproxen - 250mg | 7920 | 100714/1 | PROXEN 250 | 250mg | 20 | Tablet, film coated | Oral | Mersaco | Farmaceutici Formenti SpA | Italy | 542,912 L.L | 23.08 | A1 | Stada Arzneimittel AG | Germany | 2/5/2024 | 0 |